POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.764
https://www.valueinhealthjournal.com/article/S1098-3015(21)02559-6/fulltext
Title :
POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02559-6&doi=10.1016/j.jval.2021.11.764
First page :
Section Title :
Open access? :
No
Section Order :
10293